Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

April 1, 2026

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Knee Osteoarthritis
Interventions
DRUG

inulin

Inulin is a fermentable prebiotic fiber derived from chicory root. For this study, inulin is packaged into single-dose sachets containing 5 g, 10 g, or 15 g of powder. Participants in the 10 g arm escalate from 5 g/day for 3 days to 10 g/day, then continue with sachets containing a 2:1 blend of inulin and maltodextrin to provide a daily 10 g inulin dose. Participants in the 15 g arm escalate from 5 g/day for 3 days, 10 g/day for 4 days, then 15 g/day for the remaining 8 weeks. Sachets are mixed with food or beverage and taken once daily with the largest meal.

DRUG

Maltodextrin (Placebo)

Maltodextrin is a carbohydrate powder widely used as a food additive. For this study, maltodextrin is used as the placebo comparator. It is packaged into single-dose sachets identical in appearance and taste to inulin sachets. Participants receive escalating doses (5 g/day for 3 days, 10 g/day for 4 days, then 15 g/day) for a total of 8 weeks. Sachets are mixed with food or beverage and taken once daily with the largest meal.

Trial Locations (1)

06516

VA Connecticut Healthcare System, West Haven Campus, West Haven

All Listed Sponsors
collaborator

VA Connecticut Healthcare System

FED

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Yale University

OTHER